Status:
COMPLETED
Transcutaneous Auricular Vagus Nerve Stimulation in Upper Extremity Lymphedema
Lead Sponsor:
Seda Saka
Conditions:
Quality of Life
Lymphedema
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Lymphedema is an inflammatory disease characterized by abnormal accumulation of excess water, plasma proteins, and extravascular blood and parenchymal cells in the affected upper and lower arms, chest...
Detailed Description
Demographic data related to the patient will be questioned with the Demographic Data and Anamnesis form prepared by the researchers. Circumference measurement was determined as the primary outcome mea...
Eligibility Criteria
Inclusion
- Between the ages of 18-65
- Diagnosed with secondary lymphedema disease by the physician
- Minimum of three months after surgery
- Stage 2 and 3 patients
- Native speaker Turkish
- Individuals who agreed to participate in the study
Exclusion
- Individuals with any neurological or orthopedic problems in the upper extremity
- Individuals undergoing upper extremity surgery
- Presence of cardiac edema
- Presence of arterial disease
- Presence of acute venous disease
- Those with sensory impairment
- Those with cardiac rhythm disorders
- Individuals with cooperation problems
Key Trial Info
Start Date :
September 11 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 11 2024
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT06069908
Start Date
September 11 2023
End Date
December 11 2024
Last Update
August 5 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Gaziosmanpaşa Training and Research Hospital
Istanbul, Gaziosmanpaşa, Turkey (Türkiye), 34255
2
Halic University
Istanbul, Turkey (Türkiye)